';
Authors Posts by Cathy Barrick

Cathy Barrick

693 POSTS 0 COMMENTS

These forums are being held to support provider preparedness. The Office of Development Programs (ODP) will review the quarterly forums and discuss data presented to the Information Sharing and Advisory Committee (ISAC) Provider Performance Review Subcommittee. ODP will also review the emerging themes or trends with the implementation of performance-based contracting.

Audience:
Residential Providers

Dates and Registration Links:

March 11, 2026, 2:00 pm – 3:30 PM
Performance Based Contracting Quarterly Provider Forum – Residential

June 10, 2026, 1:30 pm – 3:00 pm
Performance Based Contracting Quarterly Provider Forum – Residential

September 9, 2026, 2:00 pm – 3:30 pm
Performance Based Contracting Quarterly Provider Forum – Residential

December 9, 2026, 1:30 pm – 3:00 pm
Performance Based Contracting Quarterly Provider Forum – Residential

These forums are being provided to support provider preparedness. The Office of Development Programs (ODP) will review the quarterly forums and discuss data presented to the Information Sharing and Advisory Committee (ISAC) Provider Performance Review Subcommittee. ODP will also review the emerging themes or trends with the implementation of performance-based contracting.

Audience:
Supports Coordination Organization (SCO)

Dates and Registration Links:

Tuesday, March 3, 2026, 1:00 pm – 2:30 pm
Performance Based Contracting Quarterly Provider Forum – Supports Coordination Organization (SCO)

Tuesday, June 2, 2026, 10:00 am – 11:30 am
Performance Based Contracting Quarterly Provider Forum – Supports Coordination Organization (SCO)

Tuesday, September 1, 2026, 1:00 pm – 2:30 pm
Performance Based Contracting Quarterly Provider Forum – Supports Coordination Organization (SCO)

Tuesday, December 1, 2026, 1:00 pm – 2:30 pm
Performance Based Contracting Quarterly Provider Forum – Supports Coordination Organization (SCO)

The United States General Services Administration has announced a change for the rate of transportation mile reimbursement rate, procedure code W7271, beginning January 1, 2026. The new rate is $0.725 per mile. Communication ODPANN 26-005 provides notice of the rate change, as well as instructions for Supports Coordination Organizations (SCO) on how to add transportation mileage to the vendor screen. It also instructs direct service providers on how to submit claim adjustments, if applicable. Please view the announcement for additional information and details.

NOTE: The release of this communication obsoletes ODP Announcement 25-004.

The Office of Developmental Programs (ODP) has shared communication ODPANN 26-004, in order to share the updated Provider Qualification Process. The Centers for Medicare and Medicaid Services (CMS) require a statewide process to ensure providers are qualified to render services to waiver-funded individuals. The Provider Qualification Process described in this communication outlines the steps the assigned Administrative Entity (AE) and provider must follow to meet these requirements, and the steps Supports Coordinators (SCs) take to transition individuals if needed. This communication does not describe the qualification process for SC organizations.

The release of this communication obsoletes ODP Announcement 25-014 Provider Qualification Process Update. Please review the announcement for more details.

The Office of Developmental Programs (ODP) has shared communication ODPANN 26-003. The purpose of this communication is to announce the release of the ISP Manual that includes changes due to the January 1, 2026 amendments to the Consolidated, Community Living, and Person/Family-Directed Support waivers. Please review the announcement for more details.

ATTACHMENTS:

assistance, support, guidance - business concept words in color hexagons over blue background, flat design

The Office of Developmental Programs (ODP) has shared ODPANN 26-002The purpose of this communication is to provide guidance regarding the intent and purpose of an Individual Support Plan (ISP) meeting and whether attending an ISP meeting is a billable unit of service.

Please view the announcement for more details. Questions about this announcement should be directed to the appropriate ODP BSASP Regional Office.

Dexcom Issues Correction for Dexcom G6 and G6 Pro Software:

This recall involves correcting devices and does not involve removing the devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction.

Affected Product

  • Product Name: Dexcom G6 Continuous Glucose Monitoring System G6 and G6 Pro Android US CGM App, Version 1.15.0
  • This correction only affects users of v.1.15.0 of the Android US App and does not apply to other users. All affected devices have been updated to resolve this issue.
  • Unique Device Identifier (UDI): SW11678: 00386270000811

What to Do
Upgrade from app version 1.15.0 as soon as possible.

On September 18, Dexcom Inc. sent all affected customers an Urgent Medical Device Correction message recommending the following actions:

  • Upgrade from app version 1.15.0 as soon as possible.
    • Open App Store and search for Dexcom G6 app.
    • Install latest Dexcom G6 app version.
    • Open Dexcom G6 app.
  • Contact Technical Support at 1-844-478-1600 for further assistance.
  • Users will no longer be able to use app version 1.15.0 after October 6, 2025.

Reason for Correction
Dexcom Inc. is correcting the Dexcom G6 Continuous Glucose Monitoring System’s G6 and G6 Pro Android US CGM App version 1.15.0 due to an identified bug that can cause the app to terminate unexpectedly. As a result, the user may not receive estimated glucose values, alarms, or alerts. If a user is unaware that the app has terminated, there is potential for missed detection of a high blood sugar (hyperglycemic) or low blood sugar (hypoglycemic) event.

The use of affected product may cause serious adverse health consequences, including hyperglycemia, hypoglycemia, and death.

As of September 16, Dexcom has not reported any serious injuries or deaths associated with this issue.

Device Use
The Dexcom G6 Continuous Glucose Monitoring System is a real-time continuous glucose monitoring system that sends glucose readings to a compatible smart device or the Dexcom receiver every five minutes. The Dexcom G6 and G6 Pro Android US CGM App is an application for compatible smart devices that displays glucose levels and trends.

Contact Information
Customers in the U.S. with questions about this recall should contact Dexcom Technical Support at 1-844-478-1600.

Additional FDA Resources

Unique Device Identifier (UDI)
The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly.

How do I report a problem?
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

On July 1, 2025, the Bureau of Supports for Autism and Special Populations (BSASP) rolled out a new assessment bundle for the Adult Autism Waiver (AAW). The Office of Developmental Programs (ODP) is interested in hearing from Supports Coordinators (SC) and providers on their experiences with implementing the new assessments.

Please join ODP for a Virtual Office Hour (VOH) to share feedback, ask questions, and review resource materials.

Who should attend?
All AAW SCs and Providers

Date: January 30, 2026
Time: 10:00 am – 11:30 am
Register Here